Keywords
Pseudotumor Cerebri
Intracranial Pressure
Headache
Epidemiology
Categories
How to Cite
Funding data
-
National Center for Advancing Translational Sciences
Grant numbers UM1TR004400
Abstract
Introduction: Idiopathic Intracranial Hypertension (IIH) presents an increasing health burden with changing demographic patterns. We studied nationwide trends in IIH epidemiology, treatment patterns, and associated outcomes using a large-scale database analysis within the United States (US).
Methods: We performed a retrospective analysis using the TriNetX US Collaborative Network database (1990-2024). We investigated demographic characteristics, time-based trends, geographic distribution, treatment pathways patterns, comorbidity profiles and associated risks with IIH. We used multivariate regression, Cox proportional hazards modeling, and standardized morbidity ratios to assess various outcomes and associations.
Results: Among 51,526 patients, we found a significant increase in adult IIH incidence from 16.0 to 127.0 per 100,000 (adjusted RR: 6.94, 95% CI: 6.71-7.17). Female predominance increased over time (female-to-male ratio: 3.29, 95% CI: 3.18-3.40). Southern regions showed the highest prevalence (43.0%, n=21,417). Initial medical management success rates varied between acetazolamide (42.3%) and topiramate (28.7%). Advanced interventional procedures showed 82.5% success rates in refractory cases. Cox modeling revealed significant associations between IIH and metabolic syndrome (HR: 2.14, 95% CI: 1.89-2.39) and cardiovascular complications (HR: 1.76, 95% CI: 1.58-1.94), independent of BMI.
Conclusions: Our findings highlight IIH as a systemic disorder with significant metabolic implications beyond its neurological manifestations. The marked regional disparities and rising incidence rates, especially among adults, suggest the need for targeted healthcare strategies. Early intervention success strongly predicts favorable outcomes, supporting prompt diagnosis and treatment initiation. These results advocate for an integrated approach combining traditional IIH management with broad metabolic screening care.
References
1. Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye (London, England). 2019: 478 [PMID: 30356129, https://doi.org/10.1038/s41433-018-0238-5]
2. Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011: 1564 [PMID: 21536635, https://doi.org/10.1212/WNL.0b013e3182190f51]
3. Westgate CS, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G, Singhal R, Mitchell JL, Grech O, Markey KA, Hebenstreit D, Tennant DA, Tomlinson JW, Mollan SP, Ludwig C, Akerman I, Lavery GG, Sinclair AJ. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI insight. 2021: [PMID: 33848268, https://doi.org/10.1172/jci.insight.145346]
4. Mollan SP, Grech O, Alimajstorovic Z, Wakerley BR, Sinclair AJ. New horizons for idiopathic intracranial hypertension: advances and challenges. British medical bulletin. 2020: 118 [PMID: 33200788, https://doi.org/10.1093/bmb/ldaa034]
5. McCluskey G, Doherty-Allan R, McCarron P, Loftus AM, McCarron LV, Mulholland D, McVerry F, McCarron MO. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. European journal of neurology. 2018: 1218 [PMID: 29953685, https://doi.org/10.1111/ene.13739]
6. Hornby C, Mollan SP, Mitchell J, Markey KA, Yangou A, Wright BLC, O'Reilly MW, Sinclair AJ. What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension? Neuro-ophthalmology (Aeolus Press). 2017: 326 [PMID: 29238388, https://doi.org/10.1080/01658107.2017.1316744]
7. Portelli M, Papageorgiou PN. An update on idiopathic intracranial hypertension. Acta Neurochir (Wien). 2017: 491 [PMID: 28013373, https://doi.org/10.1007/s00701-016-3050-7]
8. Zhou C, Zhou Y, Liu L, Jiang H, Wei H, Zhou C, Ji X. Progress and recognition of idiopathic intracranial hypertension: A narrative review. CNS neuroscience & therapeutics. 2024: e14895 [PMID: 39097911, https://doi.org/10.1111/cns.14895]
9. Fraz MA, Kim BM, Chen JJ, Lum F, Chen J, Liu GT, Hamedani AG, Consortium S. Nationwide Prevalence and Geographic Variation of Idiopathic Intracranial Hypertension among Women in the United States. Ophthalmology. 2025: 476 [PMID: 39510331, https://doi.org/10.1016/j.ophtha.2024.10.031]
10. Markowitz D, Aamodt WW, Hamedani AG. Social Determinants of Health in Idiopathic Intracranial Hypertension. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024: 346 [PMID: 38170607, https://doi.org/10.1097/WNO.0000000000002073]
11. Shaia JK, Sharma N, Kumar M, Chu J, Maatouk C, Talcott K, Singh R, Cohen DA. Changes in Prevalence of Idiopathic Intracranial Hypertension in the United States Between 2015 and 2022, Stratified by Sex, Race, and Ethnicity. Neurology. 2024: e208036 [PMID: 38181397, https://doi.org/10.1212/WNL.0000000000208036]
12. Hsu HT, Cheng HC, Hou TW, Tzeng YS, Fuh JL, Chen SP, Chen WT, Lee WJ, Pai YW, Lee YC, Lirng JF, Wang SJ, Wang YF. Idiopathic intracranial hypertension in Asians: a retrospective dual-center study. The journal of headache and pain. 2024: 144 [PMID: 39232671, https://doi.org/10.1186/s10194-024-01852-w]
13. El Mekabaty A, Obuchowski NA, Luciano MG, John S, Chung CY, Moghekar A, Jones S, Hui FK. Predictors for venous sinus stent retreatment in patients with idiopathic intracranial hypertension. Journal of neurointerventional surgery. 2017: 1228 [PMID: 27965382, https://doi.org/10.1136/neurintsurg-2016-012803]
14. Shah S, Khan A, Khan M, Lakshmanan R. Paediatric idiopathic intracranial hypertension: Epidemiology, clinical features and treatment outcomes in a tertiary care centre in Western Australia. Journal of paediatrics and child health. 2024: 499 [PMID: 39014968, https://doi.org/10.1111/jpc.16622]
15. Bouthour W, Bruce BB, Newman NJ, Biousse V. Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema. Eye (London, England). 2025: 185 [PMID: 39478195, https://doi.org/10.1038/s41433-024-03408-3]
16. Azzam AY, Mortezaei A, Morsy MM, Essibayi MA, Ghozy S, Elamin O, Azab MA, Elswedy A, Altschul D, Kadirvel R, Brinjikji W, Kallmes DF. Venous sinus stenting for idiopathic intracranial hypertension: An updated Meta-analysis. Journal of the neurological sciences. 2024: 122948 [PMID: 38457956, https://doi.org/10.1016/j.jns.2024.122948]
17. Kalyvas A, Neromyliotis E, Koutsarnakis C, Komaitis S, Drosos E, Skandalakis GP, Pantazi M, Gobin YP, Stranjalis G, Patsalides A. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH). Neurosurgical review. 2021: 773 [PMID: 32335853, https://doi.org/10.1007/s10143-020-01288-1]
18. Sachdeva V, Singh G, Yadav GJN-oD. Recent Advances in the Management of Idiopathic Intracranial Hypertension (IIH)2020: 17 https://doi.org/10.1007/978-981-13-8522-3_2]
19. Cheng H, Jin H, Hu Y, Chen L, Chen Z, Zhong G. Long-term efficacy of venous sinus stenting in the treatment of idiopathic intracranial hypertension. CNS neuroscience & therapeutics. 2024: e14356 [PMID: 37469247, https://doi.org/10.1111/cns.14356]
20. Khatkar P, Hubbard JC, Hill L, Sinclair AJ, Mollan SP. Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials. Expert opinion on investigational drugs. 2023: 1123 [PMID: 38006580, https://doi.org/10.1080/13543784.2023.2288073]
21. Azzam AY, Morsy MM, Ellabban MH, Morsy AM, Zahran AA, Nassar M, Elsayed OS, Elswedy A, Elamin O, Al Zomia AS, Abukhadijah HJ, Alotaibi HA, Atallah O, Azab MA, Essibayi MA, Dmytriw AA, Morsy MD, Altschul DJ. Idiopathic Intracranial Hypertension and Cardiovascular Diseases Risk in the United Kingdom Women: An Obesity-Adjusted Risk Analysis Using Indirect Standardization2024: 2024.10.20.24315837 https://doi.org/10.1101/2024.10.20.24315837 %J medRxiv]
22. Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP, Sinclair AJ. Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom. JAMA neurology. 2019: 1088 [PMID: 31282950, https://doi.org/10.1001/jamaneurol.2019.1812]
23. Korsbaek JJ, Jensen RH, Beier D, Wibroe EA, Hagen SM, Molander LD, Gillum MP, Svart K, Hansen TF, Kogelman LJA, Westgate CSJ. Metabolic Dysfunction in New-Onset Idiopathic Intracranial Hypertension: Identification of Novel Biomarkers. Annals of neurology. 2024: 595 [PMID: 39140399, https://doi.org/10.1002/ana.27010]
24. Hornby C, Mollan SP, Botfield H, O'Reilly MW, Sinclair AJ. Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2018: 522 [PMID: 29985799, https://doi.org/10.1097/WNO.0000000000000684]
25. Alimajstorovic Z, Mollan SP, Grech O, Mitchell JL, Yiangou A, Thaller M, Lyons H, Sassani M, Seneviratne S, Hancox T, Jankevics A, Najdekr L, Dunn W, Sinclair AJ. Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study. Journal of proteome research. 2023: 1127 [PMID: 36534069, https://doi.org/10.1021/acs.jproteome.2c00449]
26. Wardman JH, Andreassen SN, Toft-Bertelsen TL, Jensen MN, Wilhjelm JE, Styrishave B, Hamann S, Heegaard S, Sinclair AJ, MacAulay N. CSF hyperdynamics in rats mimicking the obesity and androgen excess characteristic of patients with idiopathic intracranial hypertension. Fluids and barriers of the CNS. 2024: 10 [PMID: 38273331, https://doi.org/10.1186/s12987-024-00511-1]
27. Kassubek R, Weinstock D, Behler A, Muller HP, Dupuis L, Kassubek J, Ludolph AC. Morphological alterations of the hypothalamus in idiopathic intracranial hypertension. Therapeutic advances in chronic disease. 2022: 20406223221141354 [PMID: 36479140, https://doi.org/10.1177/20406223221141354]
28. Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G, Jensen RH, Gonzalez AM, Sinclair AJ. Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. Journal of pain research. 2016: 223 [PMID: 27186074, https://doi.org/10.2147/JPR.S80824]
29. Smith I, Aoun R, Lalchan R. Cerebrospinal Fluid Leak and Idiopathic Intracranial Hypertension in a Transgender Male: Is Intracranial Hypertension Hormonally Mediated? Case Rep Neurol. 2024: 213 [PMID: 39474294, https://doi.org/10.1159/000540259]
30. Colman BD, Boonstra F, Nguyen MN, Raviskanthan S, Sumithran P, White O, Hutton EJ, Fielding J, van der Walt A. Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. J Neurol Neurosurg Psychiatry. 2024: 375 [PMID: 37798095, https://doi.org/10.1136/jnnp-2023-332222]
31. Abdelghaffar M, Hussein M, Abdelkareem SA, Elshebawy H. Sex hormones, CSF and serum leptin in patients with idiopathic intracranial hypertension. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2022: 39 https://doi.org/10.1186/s41983-022-00473-x]
32. Jensen RH, Vukovic-Cvetkovic V, Korsbaek JJ, Wegener M, Hamann S, Beier D. Awareness, Diagnosis and Management of Idiopathic Intracranial Hypertension. Life (Basel). 2021: 718 [PMID: 34357090, https://doi.org/10.3390/life11070718]
33. Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wober C, Pemp B, Bsteh G. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. The journal of headache and pain. 2023: 89 [PMID: 37460968, https://doi.org/10.1186/s10194-023-01631-z]
34. Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Muller N, Zaic S, Harreiter J, Novak K, Wober C, Pemp B. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension-a comprehensive assessment of clinical outcome. European journal of neurology. 2024: e16401 [PMID: 39152571, https://doi.org/10.1111/ene.16401]
35. Andreao FF, Ferreira MY, Oliveira LB, Sousa MP, Palavani LB, Rairan LG, Tinti ISU, Junyor FS, Batista S, Bertani R, Amarillo DG, Daccach FH. Effectiveness and Safety of Ventriculoperitoneal Shunt Versus Lumboperitoneal Shunt for Idiopathic Intracranial Hypertension: A Systematic Review and Comparative Meta-Analysis. World neurosurgery. 2024: 359 [PMID: 38428810, https://doi.org/10.1016/j.wneu.2024.02.095]
36. Azzam AY, Essibayi MA, Vaishnav D, Morsy MM, Elamin O, Zomia ASA, Alotaibi HA, Alamoud A, Mohamed AA, Ahmed OS, Elswedy A, Abukhadijah HJ, Atallah O, Dmytriw AA, Altschul DJ. Cardiometabolic Outcomes in Idiopathic Intracranial Hypertension: An International Matched-Cohort Study. medRxiv. 2024: 2024.11. 12.24317203 [PMID: 39677466, https://doi.org/10.1101/2024.11.12.24317203]
37. Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW, Virdee J, Piccus R, Roque M, Mollan SP, Sinclair AJ. The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol. 2023: 851 [PMID: 36242625, https://doi.org/10.1007/s00415-022-11402-6]
38. Bsteh G, Macher S, Krajnc N, Pruckner P, Marik W, Mitsch C, Novak K, Pemp B, Wober C. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes. Headache. 2023: 601 [PMID: 36753388, https://doi.org/10.1111/head.14478]
39. Kobeissi H, Bilgin C, Ghozy S, Adusumilli G, Thurnham J, Hardy N, Xu T, Tarchand R, Kallmes KM, Brinjikji W, Kadirvel R, Chen JJ, Sinclair A, Mollan SP, Kallmes DF. Common Design and Data Elements Reported on Idiopathic Intracranial Hypertension Trials: A Systematic Review. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024: 66 [PMID: 37342870, https://doi.org/10.1097/WNO.0000000000001902]
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 ASIDE Internal Medicine